David Henry Mack - 27 Oct 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
27 Oct 2025
Net transactions value
+$302,281
Form type
4
Filing time
29 Oct 2025, 16:11:57 UTC
Previous filing
03 Jul 2025
Next filing
09 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mack David Henry President and CEO, Director C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON /s/ Robert Ticktin, by power of attorney 29 Oct 2025 0001341642

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $302,281 +220,643 +96% $1.37 451,109 27 Oct 2025 Direct F1
holding PMVP Common Stock 165,307 27 Oct 2025 See footnote F2
holding PMVP Common Stock 453,582 27 Oct 2025 See footnote F3, F4
holding PMVP Common Stock 56,978 27 Oct 2025 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -220,643 -100% $0.000000 0 27 Oct 2025 Common Stock 220,643 $1.37 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust (the "Revocable Trust").
F2 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 Includes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Revocable Trust.
F4 The shares are held of record by the Revocable Trust.
F5 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F6 The shares subject to the option are fully vested and immediately exercisable.